Jump to content

Harry Schachter

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 11:32, 10 January 2021 (Task 18 (cosmetic): eval 9 templates: del empty params (3×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Harry Schachter
Harry Schachter, Department of Biochemistry, The Hospital for Sick Children, and University of Toronto
Born (1933-02-25) February 25, 1933 (age 91)
NationalityCanadian
CitizenshipCanada
Alma materUniversity of Toronto
Known forglycosyltransferases, branched oligosaccharides, N- and O-linked glycans
SpouseJudy Schachter (Jakubovic) (m. 1958)
ChildrenAviva Eisen, Asher Schachter
AwardsFellow of the Royal Society of Canada, Cody Medal, Starr Medal, the Austrian Cross of Honour for Science and Art First Class, Rosalind Kornfeld Award for Lifetime Achievement in Glycobiology.
Scientific career
FieldsBiochemistry
InstitutionsHospital For Sick Children University of Toronto
Doctoral advisorGordon Dixon

Harry Schachter FRSC (born 25 February 1933 in Vienna, Austria) is a Canadian biochemist and glycobiologist, and professor emeritus at the University of Toronto and the Hospital For Sick Children in Toronto, Canada.

Biography

Harry Schachter was born in Vienna, Austria in 1933, to Miriam Freund, a businesswoman, and to Ulrich (Usher) Schachter, a dentist and medical doctor. Harry's father was the cousin of Austro-Hungarian and Romanian tenor and actor, Joseph Schmidt. The Schachter family fled the Nazis in 1938, escaping to Port of Spain, Trinidad. He attended secondary school at Saint Mary's College, placing first in Trinidad in the Cambridge Advanced Level Examinations, and winning the Jerningham Gold Medal[1] and the Island Scholarship in Mathematics. He also worked part-time as a reporter for the local Guardian newspaper. His family immigrated to Toronto, Canada in 1951.

Education and career

At the University of Toronto, Schachter completed his BA in Physiology and Biochemistry in 1955, his MD in 1959, and his PhD in Biochemistry (Gordon Dixon, supervisor) in 1964. Upon completion of his PhD he was appointed an assistant professor in the Department of Biochemistry. He did his post-doctoral work in glycobiology with Saul Roseman at Johns Hopkins University from 1966 to 1968. He returned to the University of Toronto in 1968, where he established his lab in the Department of Biochemistry.

In 1976, Schachter took a position in the Division of Biochemistry Research at the Hospital for Sick Children, which he headed for 13 years. From 1984 to 1989 he also chaired the Department of Biochemistry at the University of Toronto.[2]

His contributions to the field of carbohydrate biochemistry include the discovery and characterization of 12 glycosyltransferases involved in the synthesis of N- and O-linked glycans, thereby defining processes crucial for the formation of branched oligosaccharides on glycoproteins that include cell surface receptors and secreted proteins.[3][4] Schachter also helped characterize the first Carbohydrate-Deficient Glycoprotein Syndrome (CDG-IIa; now known as Congenital Disorders of Glycosylation).[5] He helped show that GnTII null mice are excellent models for human CDG-IIa.[6] Other work on mice involving null mutations in GnTI, GnTII and GnTIII established the importance of N-glycans in metazoan development.[7][8] Additionally, Schachter explored the biological functions of complex carbohydrates in Drosophila brain development that demonstrated a tissue-specific role in the regulation of insulin signaling and life span.[9] His translational/clinical work also included enzymatic discoveries in the complex muscle-eye-brain diseases (e.g. congenital muscular dystrophy) associated with defective O-glycosylation.[10] He has published over 160 scientific papers, reviews, and commentaries.

Schachter served as post doc supervisor and mentor to scientists in his lab, and collaborated with these and other scientists in Canada, Europe, Japan and the USA. Collaborators include David Williams, Inka Brockhausen, Clifford Lingwood, Mohan Sarkar, Pamela Stanley, Noam Harpaz, Louis Siminovitch, Jeremy Carver, Hudson Freeze, Jaak Jaeken, Jamey Marth, Hans Vliegenthart, Vernon Reinhold, Reinhart Reithmeier, Kevin Campbell, Gabrielle Boulianne, Jenny Tan, Andrew Spence, Folkert Reck, Jiri Vajsar, Saroja Narasimhan, Bob (RK) Murray, GD Longmore, Jenny Chan, and Brad Bendiak.

Awards and honors

References

  1. ^ de Verteuil, Anthony (2014). Edward Lanza Joseph and the Jews in Trinidad. Port of Spain Trinidad: Litho Press. p. 192.
  2. ^ Marian Packham. Biochemistry at the University of Toronto - A Short History.
  3. ^ Harpaz, N; Schachter, H (1980). "Control of glycoprotein synthesis. Processing of asparagine-linked oligosaccharides by one or more rat liver Golgi alpha-D-mannosidases dependent on the prior action of UDP-N-acetylglucosamine: alpha-D-mannoside beta 2-N-acetylglucosaminyltransferase I". J Biol Chem. 255: 4894–902. PMID 6445359.
  4. ^ Williams, D; Schachter, H (1980). "Mucin synthesis. I. Detection in canine submaxillary glands of an N-acetylglucosaminyltransferase which acts on mucin substrates". J Biol Chem. 255: 11247–52. PMID 6449507.
  5. ^ Tan, J; Dunn, J; Jaeken, J; Schachter, H (October 1996). "Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development". Am. J. Hum. Genet. 59: 810–7. PMC 1914797. PMID 8808595.
  6. ^ Wang, Y; Tan, J; Sutton-Smith, M; Ditto, D; Panico, M; Campbell, RM; Varki, NM; Long, JM; Jaeken, J; Levinson, SR; Wynshaw-Boris, A; Morris, HR; Le, D; Dell, A; Schachter, H; Marth, JD (2001). "Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis". Glycobiology. 11: 1051–70. doi:10.1093/glycob/11.12.1051. PMID 11805078.
  7. ^ Metzler, M; Gertz, A; Sarkar, M; Schachter, H; Schrader, JW; Marth, JD (1994). "Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development". EMBO J. 13: 2056–65. doi:10.1002/j.1460-2075.1994.tb06480.x. PMC 395055. PMID 8187759.
  8. ^ Priatel, JJ; Sarkar, M; Schachter, H; Marth, JD (1997). "Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction". Glycobiology. 7: 45–56. doi:10.1093/glycob/7.1.45. PMID 9061364.
  9. ^ Sarkar, M; Leventis, PA; Silvescu, CI; Reinhold, VN; Schachter, H; Boulianne, GL (2006). "Null mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in locomotion and a reduced life span". J Biol Chem. 281: 12776–85. doi:10.1074/jbc.M512769200. PMID 16522637.
  10. ^ Willer, T; Lee, H; Lommel, M; Yoshida-Moriguchi, T; de Bernabe, DB; Venzke, D; Cirak, S; Schachter, H; Vajsar, J; Voit, T; Muntoni, F; Loder, AS; Dobyns, WB; Winder, TL; Strahl, S; Mathews, KD; Nelson, SF; Moore, SA; Campbell, KP (2012). "ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome". Nat Genet. 44: 575–80. doi:10.1038/ng.2252. PMC 3371168. PMID 22522420.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Harry_Schachter&oldid=999480067"